Skip to main content

Want a detailed portfolio tracker?

Lexaria Bioscience (LEXX) P/E (2016 - 2026)

Lexaria Bioscience (LEXX) P/E from May 12, 2016 to Jul 21, 2026. The TTM Lexaria Bioscience (LEXX) P/E is -1.59. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Lexaria Bioscience (LEXX)

YearP/EChange
2026-1.59+44.23%
2025-1.10-77.38%
2024-4.87+259.02%
2023-1.36-29.23%
2022-1.92-9.30%
2021-2.11-62.96%
2020-5.70-116.48%
201934.62-56.58%
201879.73-253.43%
2017-51.97+330.30%
2016-12.08N/A

Comparison Lexaria Bioscience (LEXX) P/E with competitors

Lexaria Bioscience (LEXX) P/E is -1.59.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.11%
NBYStablecoin Development Corp0.00-100.27%
ENLVEnlivex Ltd0.07-104.71%
FGENFibroGen Inc0.24-115.11%
CHRSCoherus Biosciences Inc0.85-153.41%
FBIOFortress Biotech Inc0.95-159.73%
ORMPOramed Pharmaceuticals Inc1.50-194.60%
AGENAgenus Inc3.01-289.43%
INVAInnoviva Inc3.15-298.51%
VXRTVaxart Inc3.55-323.42%
CRMDCorMedix Inc3.63-328.37%
CVACCureVac N.V.4.45-379.81%
GLPGGalapagos NV4.86-405.82%
SRPTSarepta Therapeutics Inc4.88-407.28%
ABEOAbeona Therapeutics Inc5.39-439.09%
ABUSArbutus Biopharma Corp5.60-452.19%
ZVRAZevra Therapeutics Inc5.89-470.54%
SPROSpero Therapeutics Inc6.23-492.02%
CGENCompugen Ltd6.31-497.40%
RIGLRigel Pharmaceuticals6.87-532.53%
SLXNSilexion Therapeutics Corp7.30-559.22%
OMEROmeros Corporation9.26-682.75%
AUPHAurinia Pharmaceuticals Inc9.58-703.28%
PLXProtalix BioTherapeutics Inc10.89-785.48%
ACADAcadia Pharmaceuticals Inc11.73-838.20%
TBPHTheravance Biopharma Inc12.26-871.78%
ADMAAdma Biologics Inc12.42-881.60%
HRMYHarmony Biosciences Holdings Inc13.82-969.85%
SABSSAB Biotherapeutics Inc14.14-989.74%
NAGENiagen Bioscience Inc14.82-1032.66%
INCYIncyte Corp15.82-1095.88%
REGNRegeneron Pharmaceuticals Inc15.86-1098.02%
PBYIPuma Biotechnology Inc17.32-1189.86%
CPRXCatalyst Pharmaceuticals Inc17.44-1197.64%
EXELExelixis Inc17.54-1203.85%
TGTXTG Therapeutics Inc18.97-1293.73%
MDXGMimedx Group Inc20.55-1393.58%
XOMAXOMA Royalty Corp22.87-1539.78%
ARGXArgen X SE24.30-1629.37%
CTMXCytomX Therapeutics Inc24.82-1662.29%
XOMAOXOMA Royalty Corp25.34-1695.25%
HALOHalozyme Therapeutics Inc25.62-1712.81%
XOMAPXOMA Royalty Corp25.67-1715.73%
VRTXVertex Pharmaceuticals Inc27.99-1862.04%
RPRXRoyalty Pharma plc - Class A28.69-1905.65%
SLNOSoleno Therapeutics Inc29.02-1926.28%
ASNDAscendis Pharma A/S30.09-1993.64%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2486.26%
APLSApellis Pharmaceuticals Inc39.02-2556.07%
BMRNBiomarin Pharmaceutical Inc42.21-2756.90%
KRYSKrystal Biotech Inc45.34-2954.01%
ONCBeiGene Ltd69.54-4477.02%
PHARPharming Group N.V.75.03-4822.26%
TECHBio-Techne Corp101.96-6517.47%
VCELVericel Corp109.92-7018.67%
ALNYAlnylam Pharmaceuticals Inc117.96-7524.97%
GMABGenmab140.29-8930.19%
TLXTelix Pharmaceuticals Ltd162.15-10306.23%
CORTCorcept Therapeutics Inc212.86-13497.69%